Ovoca Bio Loss Widens; Prepares For Market Approval Filing For Libicore
(Alliance News) - Ovoca Bio PLC on Friday said its annual loss widened heavily as a result of administration expenses and said it is preparing to file for marketing approval of its drug BP101 in a Read More